# Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation

> **NCT01203202** · PHASE2 · COMPLETED · sponsor: **Symyoo** · enrollment: 104 (actual)

## Conditions studied

- Premature Ejaculation

## Interventions

- **DRUG:** Clomipramine

## Key facts

- **NCT ID:** NCT01203202
- **Lead sponsor:** Symyoo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2012-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01203202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01203202, "Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01203202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*